Regional Medical Scientific Director-Thoracic Malignancies (Los Angeles)
Merck
- Location
- REMOTE, REMOTE, United States of America
- Employment
- Full Time
- Work model
- Remote
- Level
- Staff
- Salary
- $210.4k – $331.1k/yr
- Posted
- Aug 28, 2026
Skills
About this role
Job Description
Our Medical Affairs team advances patient care by engaging in scientific exchange with external medical experts and industry leaders ensuring the scientific value of our products is understood. We connect, communicate and train internal employees to ensure a thorough understanding of the science behind the medicine and review further unmet medical needs to support collaboration to further differentiate our portfolio. The Oncology Regional Medical Scientific Director, RMSD, is a credentialed (i.e., MD, PhD, or PharmD) therapeutic and disease expert who engages in scientific exchange with leaders in the external medical and scientific community. Scientific exchange does not include promotional claims about any drug, vaccine or biologic product. The Regional Medical Scientific Director provide to Scientific Leaders (SLs) balanced, factual, scientific information about non-product areas of interest to the company. The Regional Medical Scientific Director provides research support to our Investigator-Sponsored and Company-Sponsored Trials to enhance the understanding of the scientific foundations and goals of the study, support patient enrollment and retention efforts for a given study or address Investigator questions. The Regional Medical Scientific Director also respond to scientific questions from SLs, including questions about company products. The Regional Medical Scientific Director have no sales objectives or accountability for prescribing or sales of any company product and are required to avoid any situations that could create the appearance that they have such responsibilities. A Regional Medical Scientific Director may not comment on or make suggestions with respect to the diagnosis, treatment, or circumstances of a specific patient.
Primary Responsibilities
Develop professional relationships and communicate with national and regional scientific leaders to ensure access to medical and scientific information on areas of therapeutic interest and company products. Conduct peer to peer scientific discussions and maintain a reliable presence with those scientific leaders to ensure they have a medical contact within the company. Upon request from Global Clinical Trial Operations (GCTO), support Company-Sponsored Trials to enhance the understanding of scientific foundations and goals of the study, support patient enrollment and retention efforts or address investigator questions. May initiate discussion with potential investigators to determine the level of interest and qualifications for a specific compound or trial. Recommend potential study sites to Global Clinical Trial Operations (GCTO)/Clinical Research. Address requests from investigators for information regarding participation in our Research and Development Division's studies. Address scientific questions. Studies to enhance the understanding of the scientific foundations and goals of the study, support patient enrollment and retention efforts or address investigator questions. Investigator-Sponsored upon request from Global Center for Scientific Affairs (GCSA), support company Share the company's "˜areas of interest' and discuss study concepts to assess scientific merit and alignment with the company's research strategies. Respond to unsolicited requests for assistance from potential investigators in submitting research proposals by providing internal guidelines or technical and scientific advice. Education and training to maintain current knowledge and understanding of dynamic scientific and clinical environment in the company's areas of interest. Direct scientific leader inquiries on issues outside of RMSD scope of responsibilities (e.g., grants) to appropriate company resources consistent with applicable policies. When requested by our Research and Development Division, serve as a resource for the identification of potential investigators for consideration for participating in phase II-IV clinical development programs In response to unsolicited